- Home
- BRN vs NRSN Comparison
BRN vs NRSN Comparison
Compare BRN & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- NRSN
- Stock Information
- Founded
- BRN 1956
- NRSN 2017
- Country
- BRN United States
- NRSN Israel
- Employees
- BRN N/A
- NRSN N/A
- Industry
- BRN Oil & Gas Production
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- NRSN Health Care
- Exchange
- BRN Nasdaq
- NRSN Nasdaq
- Market Cap
- BRN 16.9M
- NRSN 17.8M
- IPO Year
- BRN N/A
- NRSN 2021
- Fundamental
- Price
- BRN $1.46
- NRSN $1.10
- Analyst Decision
- BRN
- NRSN Hold
- Analyst Count
- BRN 0
- NRSN 1
- Target Price
- BRN N/A
- NRSN N/A
- AVG Volume (30 Days)
- BRN 26.5K
- NRSN 312.6K
- Earning Date
- BRN 12-16-2024
- NRSN 12-24-2024
- Dividend Yield
- BRN N/A
- NRSN N/A
- EPS Growth
- BRN N/A
- NRSN N/A
- EPS
- BRN N/A
- NRSN N/A
- Revenue
- BRN $24,300,000.00
- NRSN N/A
- Revenue This Year
- BRN N/A
- NRSN N/A
- Revenue Next Year
- BRN N/A
- NRSN N/A
- P/E Ratio
- BRN N/A
- NRSN N/A
- Revenue Growth
- BRN N/A
- NRSN N/A
- 52 Week Low
- BRN $1.46
- NRSN $0.51
- 52 Week High
- BRN $3.20
- NRSN $2.33
- Technical
- Relative Strength Index (RSI)
- BRN 36.90
- NRSN 55.43
- Support Level
- BRN $1.46
- NRSN $0.80
- Resistance Level
- BRN $1.73
- NRSN $1.29
- Average True Range (ATR)
- BRN 0.08
- NRSN 0.13
- MACD
- BRN -0.00
- NRSN 0.01
- Stochastic Oscillator
- BRN 19.97
- NRSN 64.58
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.